AR014626A1 - Piridino arilpiperazinas sustituidas utiles en el tratamiento de hiperplasia prostatica benigna, una composicion farmaceutica que las comprende y el uso de las mismas para la fabricacion de un medicamento. - Google Patents

Piridino arilpiperazinas sustituidas utiles en el tratamiento de hiperplasia prostatica benigna, una composicion farmaceutica que las comprende y el uso de las mismas para la fabricacion de un medicamento.

Info

Publication number
AR014626A1
AR014626A1 ARP990100675A ARP990100675A AR014626A1 AR 014626 A1 AR014626 A1 AR 014626A1 AR P990100675 A ARP990100675 A AR P990100675A AR P990100675 A ARP990100675 A AR P990100675A AR 014626 A1 AR014626 A1 AR 014626A1
Authority
AR
Argentina
Prior art keywords
alkyl
substituted
independently selected
phenyl
substituents
Prior art date
Application number
ARP990100675A
Other languages
English (en)
Spanish (es)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR014626A1 publication Critical patent/AR014626A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ARP990100675A 1998-02-20 1999-02-23 Piridino arilpiperazinas sustituidas utiles en el tratamiento de hiperplasia prostatica benigna, una composicion farmaceutica que las comprende y el uso de las mismas para la fabricacion de un medicamento. AR014626A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20

Publications (1)

Publication Number Publication Date
AR014626A1 true AR014626A1 (es) 2001-03-28

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990100675A AR014626A1 (es) 1998-02-20 1999-02-23 Piridino arilpiperazinas sustituidas utiles en el tratamiento de hiperplasia prostatica benigna, una composicion farmaceutica que las comprende y el uso de las mismas para la fabricacion de un medicamento.

Country Status (23)

Country Link
US (1) US6218396B1 (https=)
EP (1) EP1054868B1 (https=)
JP (1) JP2002503724A (https=)
KR (1) KR100591028B1 (https=)
CN (1) CN1121390C (https=)
AR (1) AR014626A1 (https=)
AT (1) ATE250580T1 (https=)
AU (1) AU766398B2 (https=)
BR (1) BR9909647A (https=)
CZ (1) CZ294136B6 (https=)
DE (1) DE69911582T2 (https=)
DK (1) DK1054868T3 (https=)
ES (1) ES2209468T3 (https=)
HU (1) HUP0100781A3 (https=)
IL (2) IL137954A0 (https=)
NO (1) NO317103B1 (https=)
NZ (1) NZ506462A (https=)
PL (1) PL342339A1 (https=)
PT (1) PT1054868E (https=)
TR (1) TR200003220T2 (https=)
TW (1) TW565555B (https=)
WO (1) WO1999042448A1 (https=)
ZA (1) ZA991315B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA001904B1 (ru) * 1997-05-12 2001-10-22 ОРТО МакНЕЙЛ ФАРМАСЬЮТИКАЛ, ИНК. Арилзамещенные пиперазины для лечения доброкачественной гиперплазии простаты
CZ2003686A3 (cs) 2000-08-08 2003-08-13 Ortho Mcneil Pharmaceutical, Inc. Neimidazolové aryloxypiperidiny
KR20060005009A (ko) 2001-12-28 2006-01-16 다케다 야쿠힌 고교 가부시키가이샤 배뇨 장애 예방제/치료제
USD545208S1 (en) 2006-09-27 2007-06-26 001 Corporation Perfume bottle and cap
EP2077262A4 (en) * 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVE AND USE THEREOF
CL2009000964A1 (es) * 2008-04-23 2010-03-26 Takeda Pharmaceuticals Co Compuestos derivados de 1-aril-2-imino-1,2-dihidropiridina-3-carboxamida, antagonista del receptor adrenergico alfa 1d, composicion farmaceutica que los comprende; y su uso para el tratamiento o profilaxis de enfermedades del tracto urinario inferior.
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
WO1999003833A1 (fr) * 1997-07-15 1999-01-28 Sankyo Company, Limited Derives de piperazine

Also Published As

Publication number Publication date
HK1030776A1 (en) 2001-05-18
DE69911582D1 (de) 2003-10-30
BR9909647A (pt) 2000-11-21
IL137954A (en) 2007-06-03
EP1054868A1 (en) 2000-11-29
AU3302599A (en) 1999-09-06
CN1291188A (zh) 2001-04-11
ES2209468T3 (es) 2004-06-16
NZ506462A (en) 2003-07-25
ZA991315B (en) 2000-11-20
NO20004141L (no) 2000-10-19
IL137954A0 (en) 2001-10-31
DE69911582T2 (de) 2005-09-15
EP1054868B1 (en) 2003-09-24
CZ294136B6 (cs) 2004-10-13
KR20010041115A (ko) 2001-05-15
DK1054868T3 (da) 2003-12-22
US6218396B1 (en) 2001-04-17
WO1999042448A1 (en) 1999-08-26
HUP0100781A3 (en) 2002-12-28
ATE250580T1 (de) 2003-10-15
AU766398B2 (en) 2003-10-16
HUP0100781A2 (hu) 2001-08-28
PL342339A1 (en) 2001-06-04
PT1054868E (pt) 2004-01-30
CN1121390C (zh) 2003-09-17
NO317103B1 (no) 2004-08-09
TR200003220T2 (tr) 2001-04-20
TW565555B (en) 2003-12-11
KR100591028B1 (ko) 2006-06-22
CZ20003044A3 (cs) 2001-04-11
NO20004141D0 (no) 2000-08-18
JP2002503724A (ja) 2002-02-05

Similar Documents

Publication Publication Date Title
AR014626A1 (es) Piridino arilpiperazinas sustituidas utiles en el tratamiento de hiperplasia prostatica benigna, una composicion farmaceutica que las comprende y el uso de las mismas para la fabricacion de un medicamento.
HRP20000380B1 (en) Oral pharmaceutical extended release dosage form
NO20101069L (no) Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva
AR032781A1 (es) Amidas ariladas de acidos furan- y tiofencarboxilicos, composiciones farmaceuticas, su utilizacion para la preparacion de medicamento como tambien las composiciones farmaceuticas que las contienen
AR002971A1 (es) COMPUESTOS DE 3-(1,2,3,6)-TETRAHIDROPIRIDIN-4-ILO Y 3-PIPERIDIN-4-ILO-1H- INDOL, AGONISTAS DE 5HT(1f) FORMULACIONES FARMACEUTICAS QUE LOS CONTIENEN YMETODOS PARA ACTIVAR DICHOS RECEPTORES 5HT(1f) Y/O PARA TRATAR LAS MIGRANAS Y DESORDENES ASOCIADOS CON ELLA.
NL300338I2 (nl) Triazolytropaanderivaten als ccr5-modulatoren
AR037503A1 (es) Compuestos derivados de 1,8-naftiridina, una composicion farmaceutica y su uso para la fabricacion de un medicamento para el tratamiento de la diabetes y trastornos relacionados
CY1111075T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν τα παραγωγα της 3-αμινο-αζετιδινης, τα νεα παραγωγα τους και η προετοιμασια τους
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
CO5640136A2 (es) Derivados de hexahidropiridoisoquinolinas inhibidores de dpp-iv y composiciones farmaceuticas que los contienen
AR038818A1 (es) Compuesto de piperidina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion
AR039936A1 (es) Formulacion farmaceutica de liberacion modificada
AR032466A1 (es) Ciclilamina sulfonamidas, utilizacion de las mismas para la manufactura de un medicamento y composiciones farmaceuticas utiles como agonistas de los receptores beta-3 adrenergicos
ATE300541T1 (de) Pyrazolopyridinderivate
ATE377001T1 (de) Pleuromutilinderivate als antimikrobielle mittel
CA2655527C (en) Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
AR039601A1 (es) Derivados de nitrosodifenilamina y composiciones farmaceuticas que los comprenden como medicamentos que se pueden utilizar en el tratamiento de patologias que se caracterizan por estres oxidativo
AR022824A1 (es) Inhibidores de metaloproteasa dihetero-sustituida
AR054688A1 (es) Alquil-piridinas como inhibidores 11-beta de la diabetes
NO20054787D0 (no) Indenderivater som farmasotiske midler
AR039935A1 (es) Formulacion farmaceutica de liberacion inmediata
DK1202954T3 (da) Nye aminobenzophenoner
AR035110A1 (es) Compuesto derivado de piperazina, uso del mismo para la preparacion de una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto
AR040140A1 (es) Derivados de esteres de camptotecina en la posicion 20
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists

Legal Events

Date Code Title Description
FG Grant, registration